↓ Skip to main content

Dove Medical Press

A Novel Multiphase Modified Ketogenic Diet: An Effective and Safe Tool for Weight Loss in Chinese Obese Patients

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, August 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
18 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
39 Mendeley
Title
A Novel Multiphase Modified Ketogenic Diet: An Effective and Safe Tool for Weight Loss in Chinese Obese Patients
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, August 2022
DOI 10.2147/dmso.s365192
Pubmed ID
Authors

Wenjun Wu, Qunyan Zhou, Peng Yuan, Dan Qiao, Shukun Deng, Haiyan Cheng, Ye Ren

X Demographics

X Demographics

The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 4 10%
Student > Master 4 10%
Student > Bachelor 4 10%
Student > Postgraduate 2 5%
Student > Ph. D. Student 2 5%
Other 1 3%
Unknown 22 56%
Readers by discipline Count As %
Nursing and Health Professions 5 13%
Medicine and Dentistry 3 8%
Biochemistry, Genetics and Molecular Biology 2 5%
Sports and Recreations 2 5%
Agricultural and Biological Sciences 1 3%
Other 3 8%
Unknown 23 59%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 September 2022.
All research outputs
#5,206,716
of 25,462,162 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#231
of 1,184 outputs
Outputs of similar age
#103,511
of 432,348 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#5
of 51 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,184 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,348 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.